Gamble Jones Investment Counsel’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $235K | Hold |
2,737
| – | – | 0.02% | 176 |
|
|
2022
Q3 | $169K | Buy |
+2,737
| New | +$173K | 0.01% | 198 |
|
|
2022
Q1 | – | Sell |
-2,987
| Closed | -$217K | – | 211 |
|
|
2021
Q4 | $217K | Sell |
2,987
-618
| -17% | -$42.6K | 0.01% | 205 |
|
|
2021
Q3 | $252K | Sell |
3,605
-100
| -3% | -$7.03K | 0.02% | 196 |
|
|
2021
Q2 | $255K | Hold |
3,705
| – | – | 0.02% | 199 |
|
|
2021
Q1 | $239K | Sell |
3,705
-2,400
| -39% | -$155K | 0.02% | 198 |
|
|
2020
Q4 | $356K | Sell |
6,105
-750
| -11% | -$45.3K | 0.02% | 174 |
|
|
2020
Q3 | $433K | Hold |
6,855
| – | – | 0.03% | 152 |
|
|
2020
Q2 | $527K | Hold |
6,855
| – | – | 0.04% | 142 |
|
|
2020
Q1 | $512K | Sell |
6,855
-345
| -5% | -$23.8K | 0.05% | 140 |
|
|
2019
Q4 | $468K | Sell |
7,200
-232
| -3% | -$15.1K | 0.04% | 161 |
|
|
2019
Q3 | $471K | Sell |
7,432
-2,055
| -22% | -$134K | 0.04% | 155 |
|
|
2019
Q2 | $641K | Sell |
9,487
-1,095
| -10% | -$72K | 0.05% | 147 |
|
|
2019
Q1 | $688K | Sell |
10,582
-1,000
| -9% | -$66.5K | 0.06% | 139 |
|
|
2018
Q4 | $724K | Sell |
11,582
-4,060
| -26% | -$284K | 0.07% | 128 |
|
|
2018
Q3 | $1.21M | Sell |
15,642
-310
| -2% | -$23.4K | 0.11% | 114 |
|
|
2018
Q2 | $1.13M | Sell |
15,952
-1,163
| -7% | -$82.1K | 0.11% | 113 |
|
|
2018
Q1 | $1.29M | Sell |
17,115
-821
| -5% | -$65.3K | 0.13% | 110 |
|
|
2017
Q4 | $1.28M | Sell |
17,936
-931
| -5% | -$70.7K | 0.12% | 107 |
|
|
2017
Q3 | $1.53M | Sell |
18,867
-3,402
| -15% | -$260K | 0.16% | 105 |
|
|
2017
Q2 | $1.58M | Sell |
22,269
-4,294
| -16% | -$286K | 0.17% | 103 |
|
|
2017
Q1 | $1.8M | Sell |
26,563
-14,779
| -36% | -$1.04M | 0.19% | 96 |
|
|
2016
Q4 | $2.96M | Sell |
41,342
-10,141
| -20% | -$754K | 0.33% | 56 |
|
|
2016
Q3 | $4.07M | Sell |
51,483
-3,336
| -6% | -$271K | 0.44% | 43 |
|
|
2016
Q2 | $4.57M | Buy |
54,819
+3,953
| +8% | +$351K | 0.5% | 42 |
|
|
2016
Q1 | $4.67M | Buy |
50,866
+263
| +0.5% | +$23.7K | 0.52% | 43 |
|
|
2015
Q4 | $5.12M | Buy |
50,603
+4,261
| +9% | +$443K | 0.57% | 40 |
|
|
2015
Q3 | $4.55M | Sell |
46,342
-360
| -0.8% | -$40K | 0.52% | 45 |
|
|
2015
Q2 | $5.47M | Buy |
46,702
+8,013
| +21% | +$876K | 0.57% | 40 |
|
|
2015
Q1 | $3.8M | Buy |
38,689
+25,614
| +196% | +$2.6M | 0.39% | 49 |
|
|
2014
Q4 | $1.23M | Buy |
13,075
+5,750
| +78% | +$595K | 0.13% | 115 |
|
|
2014
Q3 | $780K | Hold |
7,325
| – | – | 0.09% | 135 |
|
|
2014
Q2 | $607K | Hold |
7,325
| – | – | 0.07% | 157 |
|
|
2014
Q1 | $519K | Sell |
7,325
-1,025
| -12% | -$80.4K | 0.06% | 161 |
|
|
2013
Q4 | $627K | Sell |
8,350
-401
| -5% | -$27.9K | 0.07% | 146 |
|
|
2013
Q3 | $550K | Buy |
8,751
+175
| +2% | +$10.5K | 0.07% | 151 |
|
|
2013
Q2 | $440K | Buy |
+8,576
| New | +$447K | 0.06% | 171 |
|
Other funds holding GILD
Gamble Jones Investment Counsel's GILD Position: Q4 2022 in Review
Gamble Jones Investment Counsel held its Gilead Sciences (GILD) position steady in Q4 2022 at 2,737 shares worth $235K. The position accounts for 0.02% of the portfolio, ranked #176.
Gamble Jones Investment Counsel first reported a position in GILD in Q2 2013 and has held it in 37 quarters since. The position peaked at $5.47M in Q2 2015. 1,768 funds tracked by Wall St. Rank hold GILD as of Q4 2022.
- Gamble Jones Investment Counsel held 2,737 shares of Gilead Sciences worth $235K as of Q4 2022.
- Gamble Jones Investment Counsel left its Gilead Sciences share count unchanged in Q4 2022.
- Gilead Sciences made up 0.02% of Gamble Jones Investment Counsel's portfolio in Q4 2022, its #176 holding.
- Gamble Jones Investment Counsel first reported a position in Gilead Sciences in Q2 2013 and has held it in 37 quarters since.
- Gamble Jones Investment Counsel's Gilead Sciences position peaked at $5.47M in Q2 2015.
- 1,768 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.
Based on Gamble Jones Investment Counsel's 13F filing for Q4 2022, filed 8 Feb 2023.